Andes Biotechnologies S.a.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 19

Loading Chart...

6 inventors (with patents filed for the assignee):

Luis O Burzio (3 out of 10 patents)

Jaime E Villegas (3 out of 5 patents)

Veronica A Burzio (3 out of 5 patents)

4. Luis O Burzio Eriz (1 out of 4 patents)

5. Veronica A Burzio Menendez (1 out of 4 patents)

6. Jaime E Villegas Olavarria (1 out of 4 patents)

4 patents: Sort by Forward Citations

1. 9862944 - Antisense oligonucleotides for treatment of cancer stem cells (2018-01-09),

2. 9359648 - Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein (2016-06-07),

3. 8895719 - Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein (2014-11-25),

4. 8318686 - Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein (2012-11-27),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#22 in Santiago

#32 in Chile

Santiago, Chile

Andes Biotechnologies S.a.

Forward Citations = 19

6 inventors:

Luis O Burzio (3 out of 10 patents)

Jaime E Villegas (3 out of 5 patents)

Veronica A Burzio (3 out of 5 patents)

4. Luis O Burzio Eriz (1 out of 4 patents)

5. Veronica A Burzio Menendez (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Andes Biotechnologies S.a.. Retrieved from https://idiyas.com/company/andes-biotechnologies-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]